Biomarker research is a diverse but integral part of bridging the translational medicine gap, and PerkinElmer focuses on multidisciplinary approaches to the discovery, validation and monitoring of biomarkers targeted towards improving human health. With multiple technologies and platforms for investigation including in vivo imaging, tissue microenvironments, cytokine quantitation and high content analysis - our innovative solutions allow scientists to more fully understand the complex role of disease biomarkers from early discovery through phase IV stages of drug development.

Drug development research is continuing to shift to targeted protein therapeutic drugs and there is a critical need for disruptive technologies that provide rapid and consistent results throughout the protein workflow.

PerkinElmer is dedicated to helping a global user community of researchers and manufacturers accelerate the assessment, development and production of biotherapeutics, vaccines and biosimilars in a validated environment.

Driven by significant scientific and technical advances over the past few decades, approaches to targeted small molecule discovery have undergone rapid change.

PerkinElmer’s innovative molecular, in vitro and in vivo approaches to target discovery, screening, lead optimization and pre-clinical testing enable scientists to make better decisions at every step. Our wide range of assays and reagents, imaging and automation solutions, software and custom services identify more valid hits and help determine efficacy and safety earlier - resulting in a more cost-effective, efficient and predictive drug development process that accelerates candidates into clinical trials.

Significantly greater understanding is needed in every area of cellular research, from in-depth studies of single cells using microscopy techniques, to screening cell populations or analyzing complex tissues. Whether you are identifying new targets for biotherapeutics, validating predictions from genomics data or finding new lead compounds in drug discovery.

PerkinElmer’s live cell and 3D imaging platforms, high content screening and image analysis solutions provide scientists with a greater contextual understanding of the biology of disease.

Informatics Solutions

PerkinElmer is a leading provider of discovery, collaboration, and knowledge enterprise solutions, desktop software, scientific databases and consulting services.

See how our informatics solutions enable you to create, analyze and communicate chemical, biological, and scientific information more effectively.

Making A Difference

Every day around the world, we are making a difference at PerkinElmer with our customers, in our communities and at work. Find out how we help drive our mission of improving the health and safety of people and the environment, for the better.